SCREEN Act

Pub. L. 115-271

Also known as: IMD CARE Act, PASS Act of 2018, STOP Act of 2018, COACH Act of 2018, PROPER Act of 2018, REGROUP Act of 2018, Medicaid Reentry Act, REACH OUT Act of 2018, Opioid Quota Reform Act, Medicaid PARTNERSHIP Act, Medicaid IMD ADDITIONAL INFO Act, Opioid Addiction Action Plan Act, SOUND Disposal and Packaging Act, Abuse Deterrent Access Act of 2018, Preventing Drug Diversion Act of 2018, Safe Disposal of Unused Medication Act, Substance Abuse Prevention Act of 2018, SUPPORT for Patients and Communities Act, Stop Illicit Drug Importation Act of 2018, Fighting Opioid Abuse in Transportation Act, Treating Barriers to Prosperity Act of 2018, Access to Increased Drug Disposal Act of 2018, Eliminating Kickbacks in Recovery Act of 2018, Using Data To Prevent Opioid Diversion Act of 2018, Opioid Addiction Recovery Fraud Prevention Act of 2018, CHIP Mental Health and Substance Use Disorder Parity Act, Combating Opioid Abuse for Care in Hospitals Act of 2018, Preventing Addiction for Susceptible Seniors Act of 2018, Synthetics Trafficking and Overdose Prevention Act of 2018, Empowering Pharmacists in the Fight Against Opioid Abuse Act, Special Registration for Telemedicine Clarification Act of 2018, Expanding Oversight of Opioid Prescribing and Payment Act of 2018, Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018, Stop Counterfeit Drugs by Regulating and Enhancing Enforcement Now Act, Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act, Providing Reliable Options for Patients and Educational Resources Act of 2018, Reauthorizing and Extending Grants for Recovery from Opioid Use Programs Act of 2018, Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Act of 2018, Responsible Education Achieves Care and Healthy Outcomes for Users' Treatment Act of 2018, Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution Act, Medicaid Providers Are Required To Note Experiences in Record Systems to Help In-need Patients Act, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, Medicaid Institutes for Mental Disease Are Decisive in Delivering Inpatient Treatment for Individuals but Opportunities for Needed Access are Limited without Information Needed about Facility Obligations Act

121 sections of the Code credited to this law, found between Public Law 115-269, except 254 and Public Law 115-324, except 254 and 282.

• 15 U.S.C. § 45d — Unfair or deceptive acts or practices with respect to substance use disorder treatment service and products
• 18 U.S.C. § 220 — Illegal remunerations for referrals to recovery homes, clinical treatment facilities, and laboratories
• 19 U.S.C. § 58c — Fees for certain customs services
• 19 U.S.C. § 1415 — Mandatory advance electronic information for cargo and other improved customs reporting procedures
• 19 U.S.C. § 1436 — Penalties for violations of arrival, reporting, entry, and clearance requirements
• 19 U.S.C. § 1436a — Report on violations of arrival, reporting, entry, and clearance requirements and falsity or lack of manifest
• 19 U.S.C. § 1583a — Development of technology to detect illicit narcotics
• 21 U.S.C. § 331 — Prohibited acts
• 21 U.S.C. § 335a — Debarment, temporary denial of approval, and suspension
• 21 U.S.C. § 355 — New drugs
• 21 U.S.C. § 355–1 — Risk evaluation and mitigation strategies
• 21 U.S.C. § 360bbb–8d — Notification, nondistribution, and recall of controlled substances
• 21 U.S.C. § 381 — Imports and exports
• 21 U.S.C. § 384f — Strengthening FDA and CBP coordination and capacity
• 21 U.S.C. § 384g — Restricting entrance of illicit drugs
• 21 U.S.C. § 802 — Definitions
• 21 U.S.C. § 813 — Treatment of controlled substance analogues
• 21 U.S.C. § 822 — Persons required to register
• 21 U.S.C. § 823 — Registration requirements
• 21 U.S.C. § 826 — Production quotas for controlled substances
• 21 U.S.C. § 827 — Records and reports of registrants
• 21 U.S.C. § 829a — Delivery of a controlled substance by a pharmacy to an administering practitioner
• 21 U.S.C. § 831 — Additional requirements relating to online pharmacies and telemedicine
• 21 U.S.C. § 832 — Suspicious orders
• 21 U.S.C. § 842 — Prohibited acts B
• 21 U.S.C. § 873 — Cooperative arrangements
• 21 U.S.C. § 1522 — Purposes
• 21 U.S.C. § 1523 — Definitions
• 21 U.S.C. § 1524 — Authorization of appropriations
• 21 U.S.C. § 1531 — Establishment of drug-free communities support program
• 21 U.S.C. § 1532 — Program authorization
• 21 U.S.C. § 1533 — Information collection and dissemination with respect to grant recipients
• 21 U.S.C. § 1535 — Supplemental grants for coalition mentoring activities
• 21 U.S.C. § 1701 — Definitions
• 21 U.S.C. § 1702 — Office of National Drug Control Policy
• 21 U.S.C. § 1703 — Appointment and duties of Director and Deputy Directors
• 21 U.S.C. § 1704 — Coordination with National Drug Control Program Agencies in demand reduction, supply reduction, and State and local affairs
• 21 U.S.C. § 1705 — National Drug Control Strategy
• 21 U.S.C. § 1706 — High Intensity Drug Trafficking Areas Program
• 21 U.S.C. § 1708 — Emerging Threats Committee, plan, and media campaign
• 21 U.S.C. § 1708a — Annual report requirement
• 21 U.S.C. § 1710 — Drug Interdiction Coordinator and Committee
• 21 U.S.C. § 1710a — Requirement for disclosure of Federal sponsorship of all Federal advertising or other communication materials
• 21 U.S.C. § 1711 — Authorization of appropriations
• 21 U.S.C. § 1714 — Awards for demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through the use of drug testing and sanctions
• 21 U.S.C. § 1715 — GAO Audit
• 26 U.S.C. § 5000A — Requirement to maintain minimum essential coverage
• 29 U.S.C. § 3225a — Addressing economic and workforce impacts of the opioid crisis
• 34 U.S.C. § 10261 — Authorization of appropriations
• 34 U.S.C. § 10381 — Authority to make public safety and community policing grants
• 38 U.S.C. § 1720F — Comprehensive program for suicide prevention among veterans
• 40 U.S.C. § 14510 — Drug abuse mitigation initiative
• 42 U.S.C. § 242t — CDC surveillance and data collection for child, youth, and adult trauma
• 42 U.S.C. § 247b–13 — Prenatal and postnatal health
• 42 U.S.C. § 247b–15 — Surveillance and education regarding infections associated with illicit drug use and other risk factors
• 42 U.S.C. § 247d–10 — Pilot program for public health laboratories to detect fentanyl and other synthetic opioids
• 42 U.S.C. § 254v — Clarification regarding service in schools and other community-based settings
• 42 U.S.C. § 280b–1 — Preventing overdoses of controlled substances
• 42 U.S.C. § 280g–3 — Prescription drug monitoring program
• 42 U.S.C. § 280h–7 — Grants to improve trauma support services and mental health care for children and youth in educational settings
• 42 U.S.C. § 280h–8 — Recognizing early childhood trauma related to substance abuse
• 42 U.S.C. § 282 — Director of National Institutes of Health
• 42 U.S.C. § 284q — Pain research
• 42 U.S.C. § 290aa–0 — National Mental Health and Substance Use Policy Laboratory
• 42 U.S.C. § 290bb — Center for Substance Abuse Treatment
• 42 U.S.C. § 290bb–1 — Residential treatment programs for pregnant and postpartum women
• 42 U.S.C. § 290bb–7 — Substance use disorder treatment and early intervention services for children, adolescents, and young adults
• 42 U.S.C. § 290bb–7a — Youth prevention and recovery
• 42 U.S.C. § 290bb–11 — Building capacity for family-focused residential treatment
• 42 U.S.C. § 290bb–21 — Center for Substance Abuse Prevention
• 42 U.S.C. § 290bb–25g — Awareness campaigns
• 42 U.S.C. § 290dd–4 — Program to support coordination and continuation of care for drug overdose patients
• 42 U.S.C. § 290ee–1 — First responder training
• 42 U.S.C. § 290ee–2 — Building communities of recovery
• 42 U.S.C. § 290ee–2a — Peer support technical assistance center
• 42 U.S.C. § 290ee–5 — National recovery housing best practices
• 42 U.S.C. § 290ee–6 — Regional Centers of Excellence in Substance Use Disorder Education
• 42 U.S.C. § 290ee–7 — Comprehensive opioid recovery centers
• 42 U.S.C. § 290ee–8 — Career Act
• 42 U.S.C. § 290ee–9 — Services for families and patients in crisis
• 42 U.S.C. § 290ee–10 — Sobriety treatment and recovery teams
• 42 U.S.C. § 290hh–1 — Grants to address the problems of persons who experience violence related stress
• 42 U.S.C. § 294e–1 — Mental and behavioral health education and training grants
• 42 U.S.C. § 294i — Program for education and training in pain care
• 42 U.S.C. § 295h — Loan repayment program for substance use disorder treatment workforce
• 42 U.S.C. § 300u–16 — Establishment of substance use disorder information dashboard
• 42 U.S.C. § 629e — Evaluations; research; technical assistance
• 42 U.S.C. § 671 — State plan for foster care and adoption assistance
• 42 U.S.C. § 1315a — Center for Medicare and Medicaid Innovation
• 42 U.S.C. § 1320a–7h — Transparency reports and reporting of physician ownership or investment interests
• 42 U.S.C. § 1320b–9b — Adult health quality measures
• 42 U.S.C. § 1395b–2 — Notice of medicare benefits; medicare and medigap information
• 42 U.S.C. § 1395l — Payment of benefits
• 42 U.S.C. § 1395m — Special payment rules for particular items and services
• 42 U.S.C. § 1395w–22 — Benefits and beneficiary protections
• 42 U.S.C. § 1395w–27 — Contracts with Medicare+Choice organizations
• 42 U.S.C. § 1395w–28 — Definitions; miscellaneous provisions
• 42 U.S.C. § 1395w–104 — Beneficiary protections for qualified prescription drug coverage
• 42 U.S.C. § 1395w–112 — Requirements for and contracts with prescription drug plan (PDP) sponsors
• 42 U.S.C. § 1395x — Definitions
• 42 U.S.C. § 1395y — Exclusions from coverage and medicare as secondary payer
• 42 U.S.C. § 1395cc — Agreements with providers of services; enrollment processes
• 42 U.S.C. § 1395cc–6 — Opioid use disorder treatment demonstration program.
• 42 U.S.C. § 1395ww — Payments to hospitals for inpatient hospital services
• 42 U.S.C. § 1395aaa–1 — Quality and efficiency measurement
• 42 U.S.C. § 1396a — State plans for medical assistance
• 42 U.S.C. § 1396b — Payment to States
• 42 U.S.C. § 1396d — Definitions
• 42 U.S.C. § 1396n — Compliance with State plan and payment provisions
• 42 U.S.C. § 1396r–8 — Payment for covered outpatient drugs
• 42 U.S.C. § 1396u–2 — Provisions relating to managed care
• 42 U.S.C. § 1396w–1 — Medicaid Improvement Fund
• 42 U.S.C. § 1396w–3a — Requirements relating to qualified prescription drug monitoring programs and prescribing certain controlled substances
• 42 U.S.C. § 1396w–4 — State option to provide coordinated care through a health home for individuals with chronic conditions
• 42 U.S.C. § 1397bb — General contents of State child health plan; eligibility; outreach
• 42 U.S.C. § 1397cc — Coverage requirements for children’s health insurance
• 42 U.S.C. § 1397jj — Definitions
• 42 U.S.C. § 5106 — Grants to States, Indian tribes or tribal organizations, and public or private agencies and organizations
• 42 U.S.C. § 290ee–3a — Grant program for State and Tribal response to opioid use disorders
• 42 U.S.C. § 290ee–5a — Sobriety treatment and recovery teams
• 42 U.S.C. § 294i–1 — Emergency department alternatives to opioids program